Human CRISPR Trials To Begin Soon

The first U.S. human trial using CRISPR to treat disease could kick off any day now. The trial is led by the University of Pennsylvania. It will use the gene-editing tool to modify immune cells, prompting them to attack three different types of cancer.
A spokesperson from Penn Medicine confirmed to Gizmodo that trial preparations are in the final stages. It did not specify when exactly it will start.
The study will enroll as many as 18 patients with myeloma, sarcoma, and melanoma cancers.